206 related articles for article (PubMed ID: 3983900)
1. Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survival.
Cattaneo M; Winocour PD; Somers DA; Groves HM; Kinlough-Rathbone RL; Packham MA; Mustard JF
Thromb Res; 1985 Jan; 37(1):29-43. PubMed ID: 3983900
[TBL] [Abstract][Full Text] [Related]
2. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
[TBL] [Abstract][Full Text] [Related]
3. Effect of aspirin and sodium salicylate on thrombosis, fibrinolysis, prothrombin time, and platelet survival In rabbits with indwelling aortic catheters.
Cattaneo M; Chahil A; Somers D; Kinlough-Rathbone RL; Packham MA; Mustard JF
Blood; 1983 Feb; 61(2):353-61. PubMed ID: 6821701
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet adherence to damaged surface of rabbit aorta.
Cazenave JP; Packham MA; Guccione MA; Mustard JF
J Lab Clin Med; 1975 Oct; 86(4):551-63. PubMed ID: 1176809
[TBL] [Abstract][Full Text] [Related]
5. Platelet survival and thrombosis.
Winocour PD; Cattaneo M; Somers D; Richardson M; Kinlough-Rathbone RL; Mustard JF
Arteriosclerosis; 1982; 2(6):458-66. PubMed ID: 7181734
[TBL] [Abstract][Full Text] [Related]
6. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
7. Drug effects on platelet adherence to collagen and damaged vessel walls.
Packham MA; Cazenave JP; Kinlough-Rathbone RL; Mustard JF
Adv Exp Med Biol; 1978; 109():253-76. PubMed ID: 364949
[TBL] [Abstract][Full Text] [Related]
8. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet aggregation by a new agent, Ticlopidine.
Ashida SI; Abiko Y
Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
[TBL] [Abstract][Full Text] [Related]
10. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
[TBL] [Abstract][Full Text] [Related]
11. The effect of ticlopidine on the aggregation of rat blood platelets and on the formation of metabolites from arachidonic acid and 8,11,14-eicosatrienoic acid in rat platelets during aggregation, and in the rat kidney.
Vincent JE; Zijlstra FJ; vd Veerdonk MA; Bonta IL
Agents Actions; 1982 Jul; 12(3):377-81. PubMed ID: 6814210
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the antiaggregating effect of ticlopidine in whole blood, platelet-rich plasma and washed platelets of the rat.
Randon J; Lefort J; Vargaftig BB
Thromb Res; 1982 Apr; 26(1):13-20. PubMed ID: 7048623
[TBL] [Abstract][Full Text] [Related]
13. Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty.
Fredrickson BJ; Turner NA; Kleiman NS; Graziadei N; Maresh K; Mascelli MA; Effron MB; McIntire LV
Circulation; 2000 Mar; 101(10):1122-9. PubMed ID: 10715258
[TBL] [Abstract][Full Text] [Related]
14. Ticlopidine inhibits platelet thrombus formation studied in a flowing system.
Escolar G; Bastida E; Castillo R; Ordinas A
Thromb Res; 1987 Mar; 45(5):561-71. PubMed ID: 3590092
[TBL] [Abstract][Full Text] [Related]
15. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.
Lalau Keraly C; Delautier D; Delabassee D; Chignard M; Benveniste J
Thromb Res; 1984 Jun; 34(6):463-71. PubMed ID: 6740569
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
18. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
19. Acute administration of ethanol to rabbits inhibits thrombus formation induced by indwelling aortic catheters.
Rand ML; Groves HM; Packham MA; Mustard JF; Kinlough-Rathbone RL
Lab Invest; 1990 Dec; 63(6):742-5. PubMed ID: 2255182
[TBL] [Abstract][Full Text] [Related]
20. Spin label study of the effect of ticlopidine on platelets.
Hongo T; Setaka M; Kwan T
Jpn J Pharmacol; 1985 Sep; 39(1):59-66. PubMed ID: 2999489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
